Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer

Clinical trial NCT04085991 · TERMINATED

Trial details

NCT number: NCT04085991
Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Adenocarcinoma Prostatic Neoplasms Metastatic Prostate Cancer Metastatic Prostatic Adenocarcinoma Metastatic Prostate Carcinoma in the Soft Tissue

Start date: 2020-07-31
Primary completion: 2023-01-15
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.